Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”

Detalles Bibliográficos
Autores principales: Kazemian, Sina, Fallahi, Minoo, Kazemian, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985281/
https://www.ncbi.nlm.nih.gov/pubmed/35387665
http://dx.doi.org/10.1186/s13006-022-00473-w
_version_ 1784682334722719744
author Kazemian, Sina
Fallahi, Minoo
Kazemian, Mohammad
author_facet Kazemian, Sina
Fallahi, Minoo
Kazemian, Mohammad
author_sort Kazemian, Sina
collection PubMed
description
format Online
Article
Text
id pubmed-8985281
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89852812022-04-07 Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?” Kazemian, Sina Fallahi, Minoo Kazemian, Mohammad Int Breastfeed J Comment BioMed Central 2022-04-06 /pmc/articles/PMC8985281/ /pubmed/35387665 http://dx.doi.org/10.1186/s13006-022-00473-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Comment
Kazemian, Sina
Fallahi, Minoo
Kazemian, Mohammad
Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
title Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
title_full Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
title_fullStr Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
title_full_unstemmed Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
title_short Reply to the commentary “Liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
title_sort reply to the commentary “liquid gold: do we need to fraction fresh colostrum for oral immunotherapy in premature infants?”
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985281/
https://www.ncbi.nlm.nih.gov/pubmed/35387665
http://dx.doi.org/10.1186/s13006-022-00473-w
work_keys_str_mv AT kazemiansina replytothecommentaryliquidgolddoweneedtofractionfreshcolostrumfororalimmunotherapyinprematureinfants
AT fallahiminoo replytothecommentaryliquidgolddoweneedtofractionfreshcolostrumfororalimmunotherapyinprematureinfants
AT kazemianmohammad replytothecommentaryliquidgolddoweneedtofractionfreshcolostrumfororalimmunotherapyinprematureinfants

Ejemplares similares